Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances

Neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and society. Related scientific researches make tardy progress. One reason is that the known pathogeny is just the tip of the...

Full description

Bibliographic Details
Main Authors: Xiaoqian Niu, Jiejian Chen, Jianqing Gao
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:Asian Journal of Pharmaceutical Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S1818087618305336
id doaj-ab6a11b2bfb949ad81ca78707ad14234
record_format Article
spelling doaj-ab6a11b2bfb949ad81ca78707ad142342020-11-25T01:00:25ZengElsevierAsian Journal of Pharmaceutical Sciences1818-08762019-09-01145480496Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advancesXiaoqian Niu0Jiejian Chen1Jianqing Gao2Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, ChinaInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; Key Laboratory of Cancer Prevention and Intervention, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310058, ChinaInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; Corresponding author. Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.Neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and society. Related scientific researches make tardy progress. One reason is that the known pathogeny is just the tip of the iceberg. Another reason is that various physiological barriers, especially blood-brain barrier (BBB), hamper effective therapeutic substances from reaching site of action. Drugs in clinical treatment of neurodegenerative diseases are basically administered orally. And generally speaking, the brain targeting efficiency is pretty low. Nano-delivery technology brings hope for neurodegenerative diseases. The use of nanocarriers encapsulating molecules such as peptides and genomic medicine may enhance drug transport through the BBB in neurodegenerative disease and target relevant regions in the brain for regenerative processes. In this review, we discuss BBB composition and applications of nanocarriers -liposomes, nanoparticles, nanomicelles and new emerging exosomes in neurodegenerative diseases. Furthermore, the disadvantages and the potential neurotoxicity of nanocarriers according pharmacokinetics theory are also discussed. Keyword: Neurodegenerative diseases, Blood-brain barrier, Nanocarriers, Neurotoxicityhttp://www.sciencedirect.com/science/article/pii/S1818087618305336
collection DOAJ
language English
format Article
sources DOAJ
author Xiaoqian Niu
Jiejian Chen
Jianqing Gao
spellingShingle Xiaoqian Niu
Jiejian Chen
Jianqing Gao
Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances
Asian Journal of Pharmaceutical Sciences
author_facet Xiaoqian Niu
Jiejian Chen
Jianqing Gao
author_sort Xiaoqian Niu
title Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances
title_short Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances
title_full Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances
title_fullStr Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances
title_full_unstemmed Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances
title_sort nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: focus on recent advances
publisher Elsevier
series Asian Journal of Pharmaceutical Sciences
issn 1818-0876
publishDate 2019-09-01
description Neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and society. Related scientific researches make tardy progress. One reason is that the known pathogeny is just the tip of the iceberg. Another reason is that various physiological barriers, especially blood-brain barrier (BBB), hamper effective therapeutic substances from reaching site of action. Drugs in clinical treatment of neurodegenerative diseases are basically administered orally. And generally speaking, the brain targeting efficiency is pretty low. Nano-delivery technology brings hope for neurodegenerative diseases. The use of nanocarriers encapsulating molecules such as peptides and genomic medicine may enhance drug transport through the BBB in neurodegenerative disease and target relevant regions in the brain for regenerative processes. In this review, we discuss BBB composition and applications of nanocarriers -liposomes, nanoparticles, nanomicelles and new emerging exosomes in neurodegenerative diseases. Furthermore, the disadvantages and the potential neurotoxicity of nanocarriers according pharmacokinetics theory are also discussed. Keyword: Neurodegenerative diseases, Blood-brain barrier, Nanocarriers, Neurotoxicity
url http://www.sciencedirect.com/science/article/pii/S1818087618305336
work_keys_str_mv AT xiaoqianniu nanocarriersasapowerfulvehicletoovercomebloodbrainbarrierintreatingneurodegenerativediseasesfocusonrecentadvances
AT jiejianchen nanocarriersasapowerfulvehicletoovercomebloodbrainbarrierintreatingneurodegenerativediseasesfocusonrecentadvances
AT jianqinggao nanocarriersasapowerfulvehicletoovercomebloodbrainbarrierintreatingneurodegenerativediseasesfocusonrecentadvances
_version_ 1725213493820391424